Heme oxygenase-1 restores impaired GARPCD4 + CD25 + regulatory t cells from patients with acute coronary syndrome by upregulating LAP and GARP expression on activated t lymphocytes

Cellular Physiology and Biochemistry

Volumn 35, Issue 2, 2015, Pages 553-570

  Liu, Yuzhou ^a   Zhao, Xiaoqi ^a   Zhong, Yucheng ^a   Meng, Kai ^b   Yu, Kunwu ^a   Shi, Huairui ^a   Wu, Bangwei ^a   Tony, Hasahya ^a   Zhu, Jianghao ^a   Zhu, Ruirui ^a   Peng, Yudong ^a   Mao, Yi ^a   Cheng, Peng ^a   Mao, Xiaobo ^a   Zeng, Qiutang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE SECOND HOSPITAL OF SHANDONG UNIVERSITY   (China)

Author keywords

Acute coronary syndrome; Foxp3; GARP + CD4 + CD25 + Tregs; Heme oxygenase 1; LAP

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD4 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAMMA INTERFERON; GLYCOPROTEIN A REPETITION PREDOMINANT PROTEIN; HEME OXYGENASE 1; HEMIN; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; LATENCY ASSOCIATED PEPTIDE; MESSENGER RNA; PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; HMOX1 PROTEIN, HUMAN; LRRC32 PROTEIN, HUMAN; MEMBRANE PROTEIN; TGFB1 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ADAPTIVE IMMUNITY; ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; STABLE ANGINA PECTORIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UPREGULATION; CELL CULTURE; CYTOLOGY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED;

ACUTE CORONARY SYNDROME; ANGINA, STABLE; CELLS, CULTURED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEME OXYGENASE-1; HEMIN; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84921882327     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369719     Document Type: Article

References (49)

1. Hansson GK, Libby P, SchonbeckU, Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281-291.
2. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
3. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995; 92: 657-671.
4. Hosono M, de Boer OJ, Van Der Wal AC, Van Der Loos CM, Teeling P, Piek JJ, Ueda M, Becker AE: Increased expression of T cell activation markers (CD2S, CD26, CD4OL and CD69J in atherectomy specimens of patients with unstable angina and acute myocardial infarction. Atherosclerosis 2003468: 73-80.
5. De Palma R, Del GF, Abbate G, Chiariello M, Calabro R, Forte L, Cimmino G, Papa M Russo MG, Ambrosio G, Giombolini C, Tritto I, Notaristefano 5, Berrino L Rossi F, Golino P: Patients with acute coronary syndrome show oligoclonal T-cell recruitment within unstable plaque: Evidence for a local, intracoronary immunologic mechanism. Circulation 2006413 : 640-646.
6. Stemme S, Rymo L, Hansson GK: Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lab Invest 1991; 65: 654-660.
7. Zalai CV, KolodziejczykMD, Pilarski L ChristovA, Nation PN, Lundstrom-Hobman M, Tymchak W, Dzavik V, Humen DP, Kostuk WJ, Jablonsky G, PflugfelDer PW, Brown JE, Lucas A: Increased circulating monocyte activation in patients with unstable coronary syndromes. JAm Coll Cardiol 2001; 38: 1340-1347.
8. Daugherty A, Rateri DL: Tlymphocytes in atherosclerosis: The yin-yang of Thl and Th2 influence on lesion formation. Circ Res 2002; 90: 1039-1040.
9. Methe H, Brunner S, Wiegand D, Nabauer M, Koglin L Edelman ER: Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. JAm Coll Cardiol 2005; 45: 1939-1945.
10. Szodoray P, Timar O, Veres K, Der H, Szomjak E, Lakos G, Aleksza M, Nakken B, Szegedi G, Soltesz P: TH1/ TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 2006; 64: 336-344.
11. Frostegard L Ulfgren AK, Nyberg P, Hedin U, Swedenborg L AnDersson U, Hansson GK: Cytokine expression in adVanced human atherosclerotic plaques: Dominance of pro-inflammatory (ThlJ and macrophagestimulating cytokines. Atherosclerosis 1999445: 33-43.
12. Hashmi S, Zeng QT: Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 200647: 699-706.
13. Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, IVanov II, Littman DR, O'Shea JJ: Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206: 35-41.
14. Meng K, Zhang W, Zhong Y, Mao X, Lin Y, Huang Y, Lang M, Peng Y, Zhu Z, Liu Y, Zhao X, Yu K, Wu B, Ji Q Zeng Q: Impairment of circulating CD4CD2S (+JGARP (+J regulatory t cells in patients with acute coronary syndrome. Cell Physiol Biochem 2014; 33: 621-632.
15. Mor A, Luboshits G, Planer D, Keren G, GeorgeJ: Altered status of CD4 (+JCD2S (+J regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006; 27: 2530-2537.
16. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD2S+ regulatory T cells. Nat Immunol 2003; 4: 330-336.
17. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorDer of the scurfy mouse. Nat Genet 2001; 27: 68-73.
18. Bennett CL Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L Kelly TE, Saulsbury FT, Chance PF, Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-21.
19. Roncarolo MG, Gregori 5: Is FOXP3 a bona fide marker for human regulatory T cells? Eur J Immunol 2008; 38: 925-927.
20. Tran DQ, AnDersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM: GARP (LRRC32J is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3 + regulatory T cells. Proc Natl Acad Sci U S A 2009; 106: 13445-13450.
21. Chan DV, Somani AK, Young AS, Massari JV, Ohtola L Sugiyama H, Garaczi E, Babineau D, Cooper KD, McCormick TS: Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32J. BMC Biochem 2011; 12: 27.
22. Stockis L Colau D, Coulie PG, Lucas 5: Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. EurJ Immunol 2009; 39: 3315-3322.
23. Araujo JA, Zhang M, Yin F: Heme oxygenase-1, oxidation, inflammation, and atherosclerosis. Front Pharmacol 2012; 3: 119.
24. Liu Y, Li P, Lu L Xiong W, Oger L TetzlaffW, CynaDer M: Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol 2008; 181 : 1887-1897.
25. Pae HO, Oh GS, Choi SM, Chae SC, Kim YM, Chung KR, Chung HT: Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. Jlmmunol 2004472: 4744-4751.
26. McDaid J, Yamashita K, Chora A, Ollinger R, Strom TB, Li XC, Bach FH, Soares MP: Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. Faseb 2 00 5; 19 : 45 8-460.
27. Xia ZW, Zhong WW, Xu LQ, Sun JL, Shen QX, Wang JG, Shao L Li YZ, Yu SC: Heme oxygenase-1-mediated CD4+CD2Shigh regulatory T cells suppress allergic airway inflammation. J Immunol 2006477: 5936-5945.
28. Mor A, Planer D, Luboshits G, Afek A, Metzger 5, Chajek-Shaul T, Keren G, George J: Role of naturally occurring CD4+ CD2S+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 893-900.
29. Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K: Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation 2009420: 1996-2005.
30. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu L Sakaguchi 5: Immunologic self-tolerance maintained by CD2S+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 199840: 1969-1980.
31. Thornton AM, Shevach EM: CD4+CD2S+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998488: 287-296.
32. Caligiuri G, NicolettiA: Lymphocyte responses in acute coronary syndromes: Lack of regulation spawns deviant behaviour. Eur Heart J 2006; 27: 2485-2486.
33. Probst-Kepper M, Geffers R, Kroger A, Viegas N, Erck C, Hecht HJ, Lunsdorf H, Roubin R, MoharreghKhiabani D, Wagner K, Ocklenburg F, Jeron A, Garritsen H, Arstila TP, Kekalainen E, Balling R, Hauser H, Suer J, Weiss 5: GARP: A key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 2 00 9; 13 : 33 43-335 7.
34. Hansson GK, Hellstrand M, Rymo L, Rubbia L Gabbiani G: Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J Exp Med 1989; 170: 1595-1608.
35. Amento EP, Ehsani N, Palmer H, Libby P: Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 199 1; 11: 12 23-123 0.
36. Geng YJ, Hansson GK: Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-Derived macrophages. J Clin Invest 1992; 89: 1322-1330.
37. Soares MP, Marguti L Cunha A, Larsen R: Immunoregulatory effects of HO-i: How does it work? Curr Opin Pharmacol 2009; 9: 482-489.
38. Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA: An integral role for heme oxygenase-i and carbon monoxide in maintaining peripheral tolerance by CD4+CD2S+ regulatory T cells. J Immunol 2005i74: Si8i-5i86.
39. Choi BM, Pae HO, Jeong YR, Kim YM, Chung HT: Critical role of heme oxygenase-i in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005; 327: i066-iO7i.
40. Zhang Y, Zhang L Wu L Di C, Xia Z: Heme oxygenase-i exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Thi7 cell-mediated immune response. J Biol Chem 20i3288: 346i2-34626.
41. Gobert AP, Verriere T, Asim M, Barry DP, Piazuelo MB, de Sablet T, Delgado AG, Bravo LE, Correa P, Peek RL Chaturvedi R, Wilson KT: Heme oxygenase-i dysregulates macrophage polarization and the immune response to helicobacter pylon. J Immunol 20i4; 193: 30i3-3022.
42. Hahn SA, Stahl HF, Becker C, Correll A, SchneiDer FL Tuettenberg A, Jonuleit H: Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4 (+J T cells. Blood 20i3; 122: ii82-ii9i.
43. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, Basham B, Smith K, Chen T, Morel F, Lecron JC, Kastelein RA, Cua DL McClanahan TK, Bowman EP, de Waal MR: Development, cytokine profile and function of human interleukin i7-producing helper T cells. Nat Immunol 2007; 8: 950-957.
44. Tran DQ: TGF-beta: The sword, the wand, and the shield of FOXP3 (+J regulatory T cells. J Mol Cell Biol 20i24: 29-37.
45. Oida T, Weiner HL: TGF-beta induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. PLoS One 20i0; 5: ei5523.
46. Jiang YB, Zhang XL Tang YL, Ma GS, Shen CX, Wei Q, Zhu Q, Yao YY, Liu NF: Effects of heme oxygenase-i gene modulated mesenchymal stem cells on vasculogenesis in ischemic swine hearts. Chin Med J (EngI) 2Oiii24: 40i-407.
47. Wang R, Zhu L Dong X, Shi M, Lu C, Springer TA: GARP regulates the bioavailability and activation of TGFbeta. Mol Biol Cell 20i2; 23: ii29-ii39.
48. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF: Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD2S-T cells through Foxp3 induction and down-regulation of Smad7. Immunol 2004; 172: 5149-5153.
49. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML Greene MI, Tone M: Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008; 9: 194-202.